Rheumatoid Arthritis
-
healthOxford Study Links Adult Arthritis Risk to Fetal Joint Development
University of Oxford researchers identify PI16+ fibroblasts in fetal joints as the cellular origin of site-specific rheumatoid arthritis, offering new targets for early detection and therapy.
-
healthCAR-T Therapy Shows Promise in Refractory Rheumatoid Arthritis at EULAR 2026
Phase 1 trial reveals CAR-T cell therapy induces remission in treatment-refractory rheumatoid arthritis and systemic sclerosis.
-
healthArthritis Drug Shows Promise for Treatment-Resistant Depression
A new study suggests tocilizumab, an anti-inflammatory drug for arthritis, may help patients with depression who don't respond to standard antidepressants.
-
healthShort Methotrexate Delay After Pneumococcal Vaccine Does Not Harm RA Control
Ancillary analysis of VACIMRA trial shows 1-month methotrexate delay after PCV13 does not worsen RA disease activity, structural progression, or treatment escalation over 1 year.
-
healthPostpartum Flares Surge in Rheumatoid Arthritis Patients, French Study Finds
French GR2 cohort study reveals 62% of rheumatoid arthritis patients flare within 6 months after delivery, while spondyloarthritis activity remains stable.
-
healthNew Arthritis Risk Criteria Developed
EULAR/American College of Rheumatology created criteria for early detection of rheumatoid arthritis in at-risk individuals.
-
healthEndometriosis Triggers System-Wide Immune Dysfunction
New research reveals endometriosis affects entire immune system, causing far-reaching symptoms beyond pelvic pain.
-
healthNanotech Revolutionizes Autoimmune Disease Treatment
Precision nanomedicine targets autoimmune disorders with reduced toxicity and enhanced immune modulation, offering a new era in therapeutic care.